Jul. 25, 2011 (Canada NewsWire Group) --
Medworxx hire of Brian Goffenberg, CA, positions the company well to
maximize
margins and profitability in the continually evolving patient flow
market.
TORONTO, July 25, 2011 /CNW/ - Medworxx Inc. (TSXV: MWX), an emerging leader in clinical patient flow solutions, today announces the addition of Brian Goffenberg, CA, to the company's executive management team. Goffenberg joins in the role of Chief Financial Officer to lead expansion into the Canadian, US and UK markets. With a base representing more than 20 percent of Canadian hospitals, and multiple international clients, Medworxx is in play to meet a surging demand for clinically-based patient flow systems.
"Medworxx is so well positioned for rapid growth," said Goffenberg. "The company is on the cutting edge of clinically-based patient flow systems, and I am delighted to be here to play my part in its continued success."
Goffenberg brings expertise in financial management of information technology firms including DWL Incorporated and Delrina, now Symantec Corporation. His experience in working with NASDAQ and in international taxation will provide Medworxx with a strong financial foundation to accommodate for the demand created by the company's rising market penetration. Medworxx is publicly traded on the TSX Venture Exchange.
"Brian's experience in managing budgeting, forecasting and strategic planning all shore up our company's readiness for strong expansion," said Dan Matlow, President and CEO, Medworxx. "Brian is ideal for Medworxx as he has helped companies achieve triple-digit growth in fast-changing markets."
About Medworxx
The Medworxx Community of Care engages more than 500,000 people at over
300 hospitals across Canada, Unites States and United Kingdom to manage
daily challenges in clinical patient flow, and requirements in
compliance and education. Founded in 2004, Medworxx Inc. is based in
Toronto, Ontario, Canada and serves international markets. The company
is publicly traded on the TSX Venture Exchange (TSXV: MWX). For more
information, visit www.medworxx.com.
The statements made in this press release may contain forward-looking statements that may involve a number of risks and uncertainties. Actual events or results could differ materially from the company's expectations and projections. The TSX Venture Exchange has not reviewed this press release and neither approved nor disapproved the information contained in this press release.
Madeline Shedno
Director, Communications. Medworxx Inc.
Suite 700, 121 Richmond St West, Toronto, Canada M5H 2K1
T: 1.800.321.1591 | T:416.642.1278
mshedno@medworxx.com | www.Medworxx.com